Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more
Vivozon Healthcare Inc (082800) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.033x
Based on the latest financial reports, Vivozon Healthcare Inc (082800) has a cash flow conversion efficiency ratio of -0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.87 Billion) by net assets (₩87.70 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vivozon Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Vivozon Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vivozon Healthcare Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vivozon Healthcare Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ningbo Peace Bird Fashion
SHG:603877
|
0.044x |
|
Fennec Pharmaceuticals Inc
NASDAQ:FENC
|
-0.333x |
|
Beijing Navigation Control Technology Co. Ltd.
SHG:688282
|
N/A |
|
Prince Pipes And Fittings Limited
NSE:PRINCEPIPE
|
0.126x |
|
Southeast Cement Co Ltd
TW:1110
|
0.017x |
|
Seetel New Energy Co., Ltd.
TW:7740
|
0.272x |
|
ELEDON PHARMACEUT.DL-001
F:2TK
|
N/A |
|
Fireweed Zinc Ltd
OTCQX:FWEDF
|
-0.677x |
Annual Cash Flow Conversion Efficiency for Vivozon Healthcare Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩106.43 Billion | ₩5.73 Billion | 0.054x | +87.33% |
| 2023-12-31 | ₩104.07 Billion | ₩2.99 Billion | 0.029x | +191.55% |
| 2022-12-31 | ₩105.84 Billion | ₩-3.32 Billion | -0.031x | +84.72% |
| 2021-12-31 | ₩85.12 Billion | ₩-17.50 Billion | -0.206x | -579.12% |
| 2020-12-31 | ₩107.80 Billion | ₩4.62 Billion | 0.043x | +220.09% |
| 2019-12-31 | ₩109.00 Billion | ₩-3.89 Billion | -0.036x | +46.71% |
| 2018-12-31 | ₩68.45 Billion | ₩-4.59 Billion | -0.067x | +76.48% |
| 2017-12-31 | ₩16.10 Billion | ₩-4.59 Billion | -0.285x | -210.44% |
| 2016-12-31 | ₩22.74 Billion | ₩5.87 Billion | 0.258x | +128.52% |
| 2015-12-31 | ₩24.65 Billion | ₩2.78 Billion | 0.113x | +26.48% |
| 2014-12-31 | ₩33.90 Billion | ₩3.03 Billion | 0.089x | -- |